Incidence of Influenza-related Medical Encounters and the Associated Healthcare Resource Use and Complications Across Adult Age Groups in the United States During the 2015–2020 Influenza Seasons
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciae180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Ian McGovern und 3 weiteren Autor:innen. Beteiligte Einrichtung: CSL Seqirus, Center for Outcomes Research and Epidemiology, Waltham, Massachusetts, USA. Hauptthemen laut MEDLINE: Influenza, Human, Hospitalization, Seasons. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSL Seqirus.
Abstract (Originalsprache)
Background
Research on influenza burden in adults has focused on crude subgroups with cut-points at 65 years, limiting insight into how burden varies with increasing age. This study describes the incidence of influenza-related outpatient visits, emergency room visits, and hospitalizations, along with healthcare resource use and complications in the aging adult population.
Methods
Individuals aged ≥18 years in the United States were evaluated retrospectively in 5 seasonal cohorts (2015–2020 seasons) in strata of age with 5-year increments. Person-level electronic medical records linked to pharmacy and medical claims were used to ascertain patient characteristics and outcomes. Influenza-related medical encounters were identified based on diagnostic codes (International Classification of Diseases, 10th Edition, codes J09*–J11*).
Results
Incidence of influenza-related outpatient visits was highest among people aged 18–34 years and declined with increasing age. For emergency room visits, incidence tended to be elevated for people aged 18–34 years, relatively stable from 35 through 60, and increased rapidly after age 60 years. Hospitalization incidence remained relatively stable until about 50 years of age and then increased with age. One in 3 patients was diagnosed with pneumonia after hospitalization, regardless of age. Across seasons, age groups, and clinical settings, on average, 40.8% of individuals were prescribed antivirals and 17.2% antibiotics.
Conclusions
Incidence of influenza-related hospitalizations begins to increase around age 50 years rather than the more common cut-point of 65, whereas incidence of outpatient visits was highest among younger adults. Influenza infections frequently led to antiviral and antibiotic prescriptions, underscoring the role influenza vaccination can play in combating antimicrobial resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CSL Seqirus, Center for Outcomes Research and Epidemiology, Waltham, Massachusetts, USA.
- Veradigm, Real World Evidence, Chicago, Illinois, USA.
- CSL Seqirus, Center for Outcomes Research and Epidemiology, Amsterdam, The Netherlands.
ORCID-Profile: Ian McGovern, Mendel D M Haag
Förderung
- CSL Seqirus
Zitieren
APA
McGovern, I., Cappell, K., Bogdanov, A. N., & Haag, M. D. M. (2024). Incidence of Influenza-related Medical Encounters and the Associated Healthcare Resource Use and Complications Across Adult Age Groups in the United States During the 2015–2020 Influenza Seasons. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae180
Vancouver
McGovern I, Cappell K, Bogdanov AN, Haag MDM. Incidence of Influenza-related Medical Encounters and the Associated Healthcare Resource Use and Complications Across Adult Age Groups in the United States During the 2015–2020 Influenza Seasons. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae180
BibTeX
@article{McGovern2024,
author = {McGovern, Ian and Cappell, Katherine and Bogdanov, Alina N and Haag, Mendel D M},
title = {Incidence of Influenza-related Medical Encounters and the Associated Healthcare Resource Use and Complications Across Adult Age Groups in the United States During the 2015–2020 Influenza Seasons},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciae180}
}
EUVIMED